UNSPSC 51162724: Isalsteine

This classification denotes a mucolytic agent with the molecular formula C14H15NO6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) K0YPY57FUQ, chemically known as (- )-n-(2-((2-methyl-4-oxo-1,3-benzodioxan-2-yl)thio)propionyl)glycine. but more generally known as isalsteine, which bears US NIH Compound Identifier 3038474. European Medicines Agency schedules Isalsteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08302MIG. The term ISALSTEINE is an International Non-Proprietary Name.

UNSPSC 51162724 Isalsteine, a Commodity code, covers pharmaceutical and medical supplies that state and local agencies procure for healthcare delivery in correctional, public health, and community settings. Recent solicitations under this code show state and local governments buying parenteral nutrition and intravenous solutions for correctional healthcare, naloxone for overdose intervention, and drug deactivation systems for community health programs. The Washington State Department of Corrections and Seminole County, Florida both posted solicitations recently, reflecting procurement activity across state agencies and county health departments. Work under this code includes sourcing, delivering, and in some cases preparing specialized pharmaceutical products to multiple facilities on urgent timelines—the Washington DOC solicitation requires parenteral nutrition bags within 24 hours and other IV products within 8 hours of order, with fixed pricing locked for two years or longer.

Recent activity spans Washington and Florida, with the Washington State Department of Corrections issuing RFQ RFQQK13020 for parenteral products and services due October 7, 2026, seeking multiple contractors (up to three per region) to serve eight correctional facilities across three geographic regions through June 30, 2030. The state encourages participation from certified small, minority-owned, women-owned, and veteran-owned businesses and requires prime contractors to develop subcontractor inclusion plans. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, though the response date shown in the source (July 26, 2023) appears inconsistent with the posting date. The Washington solicitation reflects longer-term, complex healthcare supply contracting with strict delivery and insurance requirements; the Seminole County opportunity targets more straightforward commodity purchase with potential FEMA funding.